Trojaniello, Claudia http://orcid.org/0000-0002-5677-5679
Sparano, Francesca
Cioli, Eleonora
Ascierto, Paolo Antonio
Article History
Accepted: 7 March 2023
First Online: 30 March 2023
Declarations
:
: Eleonora Cioli and Francesca Sparano declare no conflict of interest. Claudia Trojaniello has participated to Sanofi Advisory Board and has received compensation. Paolo Antonio Ascierto has received grants from Bristol Myers Squibb, Roche-Genentech, Pfizer/Array, and Sanofi, consulting fees from Bristol Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Merck Serono, Pierre-Fabre, Sun Pharma, Sanofi, Idera, Sandoz, 4SC, Italfarmaco, Nektar, Pfizer/Array, Lunaphore, Medicenna, Bio-Al Health, ValoTx, Replimmune, and Bayer, and support for attending meetings and travel from Pfizer, Bio-Al Health, and Replimmune and has participated on a Data Safety Monitoring Board or Advisory Board for Bristol Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, AstraZeneca, Immunocore, Boehringer-Ingelheim, Eisai, Regeneron, Daiichi Sankyo, Oncosec, Nouscom, Seagen, and iTeos.